2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo -[1,5-c]-pyrimidine adenosine A2a receptor antagonists

Details for Australian Patent Application No. 2004233334 (hide)

Owner Schering Corporation

Inventors Chackalamannil, Samuel; Neustadt, Bernard R.; Liu, Hong; Shah, Unmesh G.; Boyle, Craig D.; Stamford, Andrew; Hao, Jinsong

Agent Griffith Hack

Pub. Number AU-B-2004233334

PCT Pub. Number WO2004/094431

Priority 60/464,840 23.04.03 US

Filing date 21 April 2004

Wipo publication date 4 November 2004

Acceptance publication date 12 August 2010

International Classifications

C07D 487/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/094431 Priority application(s): WO2004/094431

12 August 2010 Application Accepted

  Published as AU-B-2004233334

9 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233337-Upper bearing support assembly for internal turret

2004233333-Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia